Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals protein and pathway regulation in porcine circovirus type 2 infected PK-15 cells

Journal of Proteome Research

Volumn 11, Issue 2, 2012, Pages 995-1008

  Fan, Huiying ^a,b   Ye, Yu ^a,b   Luo, Yongwen ^a,b   Tong, Tiezhu ^c   Yan, Guangrong ^d   Liao, Ming ^a,b  

^a MOA Key Laboratory for Animal Vaccine Development   (China)

^b SOUTH CHINA AGRICULTURAL UNIVERSITY   (China)

^c Huizhou Entry Exit Inspection and Quarantine Bureau   (China)

^d JINAN UNIVERSITY   (China)

Author keywords

pathway analysis; porcine circovirus type 2; quantitative proteomics; stable isotope labeling with amino acids in cell culture (SILAC)

Indexed keywords

AMINO ACID; CELL PROTEIN;

ARTICLE; CELL CULTURE; CELLULAR STRESS RESPONSE; CIRCOVIRIDAE INFECTION; CIRCOVIRUS; CONTROLLED STUDY; CYTOSKELETON; FUNCTIONAL PROTEOMICS; ISOTOPE LABELING; MASS SPECTROMETRY; NONHUMAN; PORCINE CIRCOVIRUS TYPE 2; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

ANIMALS; CELL LINE; CIRCOVIRIDAE INFECTIONS; CIRCOVIRUS; DOWN-REGULATION; HOST-PATHOGEN INTERACTIONS; ISOTOPE LABELING; PROTEIN INTERACTION MAPS; PROTEINS; PROTEOME; PROTEOMICS; SIGNAL TRANSDUCTION; SWINE; UP-REGULATION;

PORCINE CIRCOVIRUS 2;

EID: 84856645718     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr200755d     Document Type: Article

References (71)

1. Cheng, C. C.; Lee, Y. F.; Lin, N. N.; Wu, C. L.; Tung, K. C.; Chiu, Y. T. Bronchiolitis obliterans organizing pneumonia in Swine associated with porcine circovirus type 2 infection J. Biomed. Biotechnol. 2011, 2011, 245728
2. Lin, C. M.; Jeng, C. R.; Hsiao, S. H.; Liu, J. P.; Chang, C. C.; Chiou, M. T.; Tsai, Y. C.; Chia, M. Y.; Pang, V. F. Immunopathological characterization of porcine circovirus type 2 infection-associated follicular changes in inguinal lymph nodes using high-throughput tissue microarray Vet. Microbiol. 2011, 149 (1-2) 72-84
3. Madec, F.; Rose, N.; Grasland, B.; Cariolet, R.; Jestin, A. Post-weaning multisystemic wasting syndrome and other PCV2-related problems in pigs: a 12-year experience Transbound Emerg. Dis. 2008, 55 (7) 273-83
4. Madson, D. M.; Patterson, A. R.; Ramamoorthy, S.; Pal, N.; Meng, X. J.; Opriessnig, T. Reproductive failure experimentally induced in sows via artificial insemination with semen spiked with porcine circovirus type 2 Vet. Pathol. 2009, 46 (4) 707-16
5. Darwich, L.; Segales, J.; Mateu, E. Pathogenesis of postweaning multisystemic wasting syndrome caused by Porcine circovirus 2: An immune riddle Arch. Virol. 2004, 149 (5) 857-74
6. Crowther, R. A.; Berriman, J. A.; Curran, W. L.; Allan, G. M.; Todd, D. Comparison of the structures of three circoviruses: chicken anemia virus, porcine circovirus type 2, and beak and feather disease virus J. Virol. 2003, 77 (24) 13036-41
7. Hamel, A. L.; Lin, L. L.; Nayar, G. P. Nucleotide sequence of porcine circovirus associated with postweaning multisystemic wasting syndrome in pigs J. Virol. 1998, 72 (6) 5262-7
8. Mankertz, A.; Persson, F.; Mankertz, J.; Blaess, G.; Buhk, H. J. Mapping and characterization of the origin of DNA replication of porcine circovirus J. Virol. 1997, 71 (3) 2562-6
9. Nawagitgul, P.; Morozov, I.; Bolin, S. R.; Harms, P. A.; Sorden, S. D.; Paul, P. S. Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein J. Gen. Virol. 2000, 81 (Pt 9) 2281-7
10. Fort, M.; Sibila, M.; Nofrarias, M.; Perez-Martin, E.; Olvera, A.; Mateu, E.; Segales, J. Porcine circovirus type 2 (PCV2) Cap and Rep proteins are involved in the development of cell-mediated immunity upon PCV2 infection Vet. Immunol. Immunopathol. 2010, 137 (3-4) 226-34
11. Liu, J.; Chen, I.; Kwang, J. Characterization of a previously unidentified viral protein in porcine circovirus type 2-infected cells and its role in virus-induced apoptosis J. Virol. 2005, 79 (13) 8262-74
12. Balmelli, C.; Steiner, E.; Moulin, H.; Peduto, N.; Herrmann, B.; Summerfield, A.; McCullough, K. Porcine circovirus type 2 DNA influences cytoskeleton rearrangements in plasmacytoid and monocyte-derived dendritic cells Immunology 2011, 132 (1) 57-65
13. Chae, J. S.; Choi, K. S. Proinflammatory cytokine expression in the lung of pigs with porcine circovirus type 2-associated respiratory disease Res. Vet. Sci. 2011, 90 (2) 321-3
14. Tsai, Y. C.; Jeng, C. R.; Hsiao, S. H.; Chang, H. W.; Liu, J. J.; Chang, C. C.; Lin, C. M.; Chia, M. Y.; Pang, V. F. Porcine circovirus type 2 (PCV2) induces cell proliferation, fusion, and chemokine expression in swine monocytic cells in vitro Vet. Res. 2010, 41 (5) 60
15. Hasslung, F. C.; Berg, M.; Allan, G. M.; Meehan, B. M.; McNeilly, F.; Fossum, C. Identification of a sequence from the genome of porcine circovirus type 2 with an inhibitory effect on IFN-alpha production by porcine PBMCs J. Gen. Virol. 2003, 84 (Pt 11) 2937-45
16. Karuppannan, A. K.; Liu, S.; Jia, Q.; Selvaraj, M.; Kwang, J. Porcine circovirus type 2 ORF3 protein competes with p53 in binding to Pirh2 and mediates the deregulation of p53 homeostasis Virology 2010, 398 (1) 1-11
17. Wei, L.; Zhu, Z.; Wang, J.; Liu, J. JNK and p38 mitogen-activated protein kinase pathways contribute to porcine circovirus type 2 infection J. Virol. 2009, 83 (12) 6039-47
18. Finsterbusch, T.; Steinfeldt, T.; Doberstein, K.; Rodner, C.; Mankertz, A. Interaction of the replication proteins and the capsid protein of porcine circovirus type 1 and 2 with host proteins Virology 2009, 386 (1) 122-31
19. Timmusk, S.; Fossum, C.; Berg, M. Porcine circovirus type 2 replicase binds the capsid protein and an intermediate filament-like protein J. Gen. Virol. 2006, 87 (Pt 11) 3215-23
20. Zhang, X.; Zhou, J.; Wu, Y.; Zheng, X.; Ma, G.; Wang, Z.; Jin, Y.; He, J.; Yan, Y. Differential proteome analysis of host cells infected with porcine circovirus type 2 J. Proteome Res. 2009, 8 (11) 5111-9
21. Emmott, E.; Wise, H.; Loucaides, E. M.; Matthews, D. A.; Digard, P.; Hiscox, J. A. Quantitative proteomics using SILAC coupled to LC-MS/MS reveals changes in the nucleolar proteome in influenza A virus-infected cells J. Proteome Res. 2010, 9 (10) 5335-45
22. Jiang, X. S.; Tang, L. Y.; Dai, J.; Zhou, H.; Li, S. J.; Xia, Q. C.; Wu, J. R.; Zeng, R. Quantitative analysis of severe acute respiratory syndrome (SARS)-associated coronavirus-infected cells using proteomic approaches: implications for cellular responses to virus infection Mol. Cell. Proteomics 2005, 4 (7) 902-13
23. Skiba, M.; Glowinski, F.; Koczan, D.; Mettenleiter, T. C.; Karger, A. Gene expression profiling of Pseudorabies virus (PrV) infected bovine cells by combination of transcript analysis and quantitative proteomic techniques Vet. Microbiol. 2010, 143 (1) 14-20
24. Emmott, E.; Rodgers, M. A.; Macdonald, A.; McCrory, S.; Ajuh, P.; Hiscox, J. A. Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus Mol. Cell. Proteomics 2010, 9 (9) 1920-36
25. Lam, Y. W.; Evans, V. C.; Heesom, K. J.; Lamond, A. I.; Matthews, D. A. Proteomics analysis of the nucleolus in adenovirus-infected cells Mol. Cell. Proteomics 2010, 9 (1) 117-30
26. Mannova, P.; Fang, R.; Wang, H.; Deng, B.; McIntosh, M. W.; Hanash, S. M.; Beretta, L. Modification of host lipid raft proteome upon hepatitis C virus replication Mol. Cell. Proteomics 2006, 5 (12) 2319-25
27. Munday, D. C.; Emmott, E.; Surtees, R.; Lardeau, C. H.; Wu, W.; Duprex, W. P.; Dove, B. K.; Barr, J. N.; Hiscox, J. A. Quantitative proteomic analysis of A549 cells infected with human respiratory syncytial virus Mol. Cell. Proteomics 2010, 9 (11) 2438-59
28. Pathak, S.; De Souza, G. A.; Salte, T.; Wiker, H. G.; Asjo, B. HIV induces both a down-regulation of IRAK-4 that impairs TLR signalling and an up-regulation of the antibiotic peptide dermcidin in monocytic cells Scand. J. Immunol. 2009, 70 (3) 264-76
29. Yan, G. R.; Xu, S. H.; Tan, Z. L.; Liu, L.; He, Q. Y. Global identification of miR-373-regulated genes in breast cancer by quantitative proteomics Proteomics 2011, 11 (5) 912-20
30. Cox, J.; Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification Nat. Biotechnol. 2008, 26 (12) 1367-72
31. Sun, J.; Jiang, Y.; Shi, Z.; Yan, Y.; Guo, H.; He, F.; Tu, C. Proteomic alteration of PK-15 cells after infection by classical swine fever virus J. Proteome Res. 2008, 7 (12) 5263-9
32. Mann, M. Functional and quantitative proteomics using SILAC Nat. Rev. Mol. Cell. Biol. 2006, 7 (12) 952-8
33. Croall, D. E.; Ersfeld, K. The calpains: modular designs and functional diversity Genome Biol. 2007, 8 (6) 218
34. Melloni, E.; Pontremoli, S. The calpains Trends Neurosci. 1989, 12 (11) 438-44
35. Perrin, C.; Vergely, C.; Rochette, L. [Calpains and cardiac diseases] Ann. Cardiol. Angeiol. (Paris) 2004, 53 (5) 259-66
36. Goll, D. E.; Thompson, V. F.; Li, H.; Wei, W.; Cong, J. The calpain system Physiol. Rev. 2003, 83 (3) 731-801
37. Boivin, P.; Galand, C.; Dhermy, D. In vitro digestion of spectrin, protein 4.1 and ankyrin by erythrocyte calcium dependent neutral protease (calpain I) Int. J. Biochem. 1990, 22 (12) 1479-89
38. Vanderklish, P. W.; Bahr, B. A. The pathogenic activation of calpain: a marker and mediator of cellular toxicity and disease states Int. J. Exp. Pathol. 2000, 81 (5) 323-39
39. Bartoli, M.; Richard, I. Calpains in muscle wasting Int. J. Biochem. Cell Biol. 2005, 37 (10) 2115-33
40. Guicciardi, M. E.; Gores, G. J. Calpains can do it alone: implications for cancer therapy Cancer Biol. Ther. 2003, 2 (2) 153-4
41. Gafni, J.; Ellerby, L. M. Calpain activation in Huntington's disease J. Neurosci. 2002, 22 (12) 4842-9
42. Garg, S.; Timm, T.; Mandelkow, E. M.; Mandelkow, E.; Wang, Y. Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment Neurobiol. Aging 2011, 32 (1) 1-14
43. Zatz, M.; Starling, A. Calpains and disease N. Engl. J. Med. 2005, 352 (23) 2413-23
44. Adamec, E.; Mohan, P.; Vonsattel, J. P.; Nixon, R. A. Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2 Acta Neuropathol. 2002, 104 (1) 92-104
45. Simonin, Y.; Disson, O.; Lerat, H.; Antoine, E.; Biname, F.; Rosenberg, A. R.; Desagher, S.; Lassus, P.; Bioulac-Sage, P.; Hibner, U. Calpain activation by hepatitis C virus proteins inhibits the extrinsic apoptotic signaling pathway Hepatology 2009, 50 (5) 1370-9
46. Zhang, F.; Wang, Q.; Ye, L.; Feng, Y.; Zhang, X. Hepatitis B virus X protein upregulates expression of calpain small subunit 1 via nuclear factor-kappaB/p65 in hepatoma cells J. Med. Virol. 2010, 82 (6) 920-8
47. Perry, S. W.; Barbieri, J.; Tong, N.; Polesskaya, O.; Pudasaini, S.; Stout, A.; Lu, R.; Kiebala, M.; Maggirwar, S. B.; Gelbard, H. A. Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax J. Neurosci. 2010, 30 (42) 14153-64
48. Blomgren, K.; Zhu, C.; Wang, X.; Karlsson, J. O.; Leverin, A. L.; Bahr, B. A.; Mallard, C.; Hagberg, H. Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of 'pathological apoptosis'? J. Biol. Chem. 2001, 276 (13) 10191-8
49. Chua, B. T.; Guo, K.; Li, P. Direct cleavage by the calcium-activated protease calpain can lead to inactivation of caspases J. Biol. Chem. 2000, 275 (7) 5131-5
50. Wood, D. E.; Thomas, A.; Devi, L. A.; Berman, Y.; Beavis, R. C.; Reed, J. C.; Newcomb, E. W. Bax cleavage is mediated by calpain during drug-induced apoptosis Oncogene 1998, 17 (9) 1069-78
51. Ruiz-Vela, A.; Gonzalez, D. B. G.; Martinez-A, C. Implication of calpain in caspase activation during B cell clonal deletion EMBO J. 1999, 18 (18) 4988-98
52. Nakagawa, T.; Yuan, J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis J. Cell Biol. 2000, 150 (4) 887-94
53. von Wnuck, L. K.; Keul, P.; Lucke, S.; Heusch, G.; Wohlschlaeger, J.; Baba, H. A.; Levkau, B. Degraded collagen induces calpain-mediated apoptosis and destruction of the X-chromosome-linked inhibitor of apoptosis (xIAP) in human vascular smooth muscle cells Cardiovasc. Res. 2006, 69 (3) 697-705
54. Liu, W.; Zi, M.; Jin, J.; Prehar, S.; Oceandy, D.; Kimura, T. E.; Lei, M.; Neyses, L.; Weston, A. H.; Cartwright, E. J.; Wang, X. Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth Circ. Res. 2009, 104 (7) 905-14
55. Ma, J.; Cao, X. Regulation of Stat3 nuclear import by importin alpha5 and importin alpha7 via two different functional sequence elements Cell Signal. 2006, 18 (8) 1117-26
56. Gabriel, G.; Herwig, A.; Klenk, H. D. Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus PLoS Pathog. 2008, 4 (2) e11
57. Fischer, N.; Kremmer, E.; Lautscham, G.; Mueller-Lantzsch, N.; Grasser, F. A. Epstein-Barr virus nuclear antigen 1 forms a complex with the nuclear transporter karyopherin alpha2 J. Biol. Chem. 1997, 272 (7) 3999-4005
58. Goodwin, D. J.; Whitehouse, A. A gamma-2 herpesvirus nucleocytoplasmic shuttle protein interacts with importin alpha 1 and alpha 5 J. Biol. Chem. 2001, 276 (23) 19905-12
59. Merle, E.; Rose, R. C.; LeRoux, L.; Moroianu, J. Nuclear import of HPV11 L1 capsid protein is mediated by karyopherin alpha2beta1 heterodimers J. Cell Biochem. 1999, 74 (4) 628-37
60. Vodicka, M. A.; Koepp, D. M.; Silver, P. A.; Emerman, M. HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection Genes Dev. 1998, 12 (2) 175-85
61. Deng, T.; Engelhardt, O. G.; Thomas, B.; Akoulitchev, A. V.; Brownlee, G. G.; Fodor, E. Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex J. Virol. 2006, 80 (24) 11911-9
62. Chongsatja, P. O.; Bourchookarn, A.; Lo, C. F.; Thongboonkerd, V.; Krittanai, C. Proteomic analysis of differentially expressed proteins in Penaeus vannamei hemocytes upon Taura syndrome virus infection Proteomics 2007, 7 (19) 3592-601
63. Zheng, X.; Hong, L.; Shi, L.; Guo, J.; Sun, Z.; Zhou, J. Proteomics analysis of host cells infected with infectious bursal disease virus Mol. Cell. Proteomics 2008, 7 (3) 612-25
64. Pocernich, C. B.; Boyd-Kimball, D.; Poon, H. F.; Thongboonkerd, V.; Lynn, B. C.; Klein, J. B.; Calebrese, V.; Nath, A.; Butterfield, D. A. Proteomics analysis of human astrocytes expressing the HIV protein Tat Brain Res. Mol. Brain Res. 2005, 133, 2
65. Chen, W.; Gao, N.; Wang, J. L.; Tian, Y. P.; Chen, Z. T.; An, J. Vimentin is required for dengue virus serotype 2 infection but microtubules are not necessary for this process Arch. Virol. 2008, 153 (9) 1777-81
66. Fang, M.; Nie, Y.; Theilmann, D. A. AcMNPV EXON0 (AC141) which is required for the efficient egress of budded virus nucleocapsids interacts with beta-tubulin Virology 2009, 385 (2) 496-504
67. Nitahara-Kasahara, Y.; Fukasawa, M.; Shinkai-Ouchi, F.; Sato, S.; Suzuki, T.; Murakami, K.; Wakita, T.; Hanada, K.; Miyamura, T.; Nishijima, M. Cellular vimentin content regulates the protein level of hepatitis C virus core protein and the hepatitis C virus production in cultured cells Virology 2009, 383 (2) 319-27
68. Khar, A.; Ali, A. M.; Pardhasaradhi, B. V.; Varalakshmi, C. H.; Anjum, R.; Kumari, A. L. Induction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: role of reactive oxygen intermediates Cell Stress Chaperones 2001, 6 (4) 368-76
69. Kotsiopriftis, M.; Tanner, J. E.; Alfieri, C. Heat shock protein 90 expression in Epstein-Barr virus-infected B cells promotes gammadelta T-cell proliferation in vitro J. Virol. 2005, 79 (11) 7255-61
70. Srivastava, P. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses Annu. Rev. Immunol. 2002, 20, 395-425
71. Wells, A. D.; Malkovsky, M. Heat shock proteins, tumor immunogenicity and antigen presentation: an integrated view Immunol. Today 2000, 21 (3) 129-32